Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Equity Average (2019 - 2025)

Historic Equity Average for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $1.1 billion.

  • IDEAYA Biosciences' Equity Average fell 556.34% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 556.34%. This contributed to the annual value of $1.0 billion for FY2025, which is 2391.59% up from last year.
  • IDEAYA Biosciences' Equity Average amounted to $1.1 billion in Q4 2025, which was down 556.34% from $1.0 billion recorded in Q3 2025.
  • IDEAYA Biosciences' 5-year Equity Average high stood at $1.1 billion for Q4 2024, and its period low was $215.7 million during Q1 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Equity Average value was $461.3 million (recorded in 2023), while the average stood at $606.3 million.
  • As far as peak fluctuations go, IDEAYA Biosciences' Equity Average surged by 12778.88% in 2024, and later tumbled by 556.34% in 2025.
  • IDEAYA Biosciences' Equity Average (Quarter) stood at $309.6 million in 2021, then rose by 16.0% to $359.1 million in 2022, then skyrocketed by 57.21% to $564.6 million in 2023, then surged by 98.34% to $1.1 billion in 2024, then dropped by 5.56% to $1.1 billion in 2025.
  • Its Equity Average stands at $1.1 billion for Q4 2025, versus $1.0 billion for Q3 2025 and $991.9 million for Q2 2025.